Oncoinvent ASA banner
O

Oncoinvent ASA
OSE:ONCIN

Watchlist Manager
Oncoinvent ASA
OSE:ONCIN
Watchlist
Price: 40.75 NOK -3.44% Market Closed
Market Cap: kr182.6m

Profitability Summary

Oncoinvent ASA's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Oncoinvent ASA

Margins Comparison
Oncoinvent ASA Competitors

Country Company Market Cap Operating
Margin
Net
Margin
NO
Oncoinvent ASA
OSE:ONCIN
182.6m NOK
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
952.4B USD
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
592.2B USD
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
286.2B CHF
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
244.8B CHF
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
234.4B GBP
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
298.8B USD
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
151.6B USD
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
125.8B USD
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Oncoinvent ASA Competitors

Country Company Market Cap ROE ROA ROCE ROIC
NO
Oncoinvent ASA
OSE:ONCIN
182.6m NOK
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
952.4B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
592.2B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
286.2B CHF
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
244.8B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
234.4B GBP
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
298.8B USD
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
151.6B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
125.8B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Oncoinvent ASA

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett